Aspirin plus calcium supplementation to prevent superimposed preeclampsia: A randomized trial

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 5, 2014, Pages 419-425

  Souza, E V ^a   Torloni, M R ^a   Atallah, A N ^a   Dos Santos, G M S ^a   Kulay, L ^a   Sass, N ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aspirin; Calcium carbonate; Doppler; Hypertension; Preeclampsia; Ultrasonography

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; PLACEBO; CALCIUM INTAKE; DRUG COMBINATION;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; LOW DRUG DOSE; PATIENT COMPLIANCE; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; SUPPLEMENTATION; VERY LOW BIRTH WEIGHT; YOUNG ADULT; BRAZIL; CALCIUM INTAKE; CHRONIC DISEASE; COMPLICATION; CONGENITAL MALFORMATION; DOPPLER FLOWMETRY; DRUG COMBINATION; HIGH RISK PREGNANCY; METHODOLOGY; PILOT STUDY; PRE-ECLAMPSIA; PREGNANCY; RISK FACTOR; THERAPEUTIC USE; TREATMENT OUTCOME; UTERINE ARTERY;

ADULT; ASPIRIN; BRAZIL; CALCIUM, DIETARY; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; HYPERTENSION; PILOT PROJECTS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, HIGH-RISK; RESEARCH DESIGN; RISK FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER; UTERINE ARTERY;

EID: 84900016888     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20143629     Document Type: Article

References (37)

1. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-1074. doi: 10.1016/S0140-6736(06)68397-9.
2. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-S22.
3. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 2008; 51: 1002-1009. doi: 10.1161/HYPERTENSIONAHA.107.107565.
4. Giannubilo SR, Dell'Uomo B, Tranquilli AL. Perinatal outcomes, blood pressure patterns and risk assessment of superimposed preeclampsia in mild chronic hypertensive pregnancy. Eur J Obstet Gynecol Reprod Biol 2006; 126: 63-67. doi: 10.1016/j.ejogrb.2005.06.042.
5. McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 1996; 103: 123-129. doi: 10.1111/j.1471-0528.1996. tb09662.x.
6. Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998; 339: 667-671. doi: 10.1056/NEJM199809033391004.
7. Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994; 171: 410-416. doi: 10.1016/0002-9378(94)90276-3.
8. Lecarpentier E, Tsatsaris V, Goffinet F, Cabrol D, Sibai B, Haddad B. Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated before pregnancy. PLoS One 2013; 8: e62140. doi: 10.1371/ journal.pone.0062140.
9. Gilbert WM, Young AL, Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med 2007; 52: 1046-1051.
10. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. Obstet Gynecol 2012; 119: 396-407. doi: 10.1097/AOG.0b013e318249ff06.
11. Henrique AJ, Borrozzino NF, Gabrielloni MC, Barbieri M, Schirmer J. [Perinatal outcome in women suffering from chronic hypertension: literature integrative review]. Rev Bras Enferm 2012; 65: 1000-1010. doi: 10.1590/S0034-71672012000600017.
12. Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH. Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 2002; 12: 78-88. doi: 10.1080/jmf.12.2.78.88.
13. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985; 1: 840-842. doi: 10.1016/S0140-6736(85)92207-X.
14. Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 1-3. doi: 10.1016/S0140-6736(86)91891-X.
15. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994; 343: 619-629. doi: 10.1016/S0140-6736(94)92633-6.
16. ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pre-eclǎmpsia com Aspirina) Collaborative Group. Br J Obstet Gynaecol 1996; 103: 39-47. doi: 10.1111/j.1471-0528.1996.tb09513.x.
17. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1993; 329: 1213-1218. doi: 10.1056/NEJM199310213 291701.
18. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998; 338: 701-705. doi: 10.1056/ NEJM199803123381101.
19. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a metaanalysis of individual patient data. Lancet 2007; 369: 1791-1798. doi: 10.1016/S0140-6736(07)60712-0.
20. Coomarasamy A, Papaioannou S, Gee H, Khan KS. Aspirin for the prevention of preeclampsia in women with abnormal uterine artery Doppler: a meta-analysis. Obstet Gynecol 2001; 98: 861-866. doi: 10.1016/S0029-7844(01)01569-1.
21. Yu CK, Papageorghiou AT, Parra M, Palma DR, Nicolaides KH. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 2003; 22: 233-239. doi: 10.1002/uog.218.
22. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010; CD001059.
23. World Health Organization. WHO Recommendations for prevention and treatment of pre-eclampsia and eclampsia. http://whqlibdoc.who.int/publications/2011/9789241548335_eng.pdf
24. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357: 209-215. doi: 10.1016/S0140-6736(00)03599-6.
25. McCowan LM, Ritchie K, Mo LY, Bascom PA, Sherret H. Uterine artery flow velocity waveforms in normal and growth-retarded pregnancies. Am J Obstet Gynecol 1988; 158: 499-504. doi: 10.1016/0002-9378(88)90013-0.
26. Yudkin PL, Aboualfa M, Eyre JA, Redman CW, Wilkinson AR. New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 1987; 15: 45-52. doi: 10.1016/0378-3782(87)90099-5.
27. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402-414. doi: 10.1097/AOG.0b013e3181e9322a.
28. Reinwald S, Weaver CM, Kester JJ. The health benefits of calcium citrate malate: a review of the supporting science. Adv Food Nutr Res 2008; 54: 219-346. doi: 10.1016/S1043-4526(07)00006-X.
29. Lopez-Jaramillo P, Casas JP, Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res 2001; 34: 1227-1235. doi: 10.1590/S0100-879X2001001000001.
30. Belizan JM, Villar J, Repke J. The relationship between calcium intake and pregnancy-induced hypertension: up-todate evidence. Am J Obstet Gynecol 1988; 158: 898-902. doi: 10.1016/0002-9378(88)90091-9.
31. Asemi Z, Samimi M, Heidarzadeh Z, Khorrammian H, Tabassi Z. A randomized controlled clinical trial investigating the effect of calcium supplement plus low-dose aspirin on hs-CRP, oxidative stress and insulin resistance in pregnant women at risk for pre-eclampsia. Pak J Biol Sci 2012; 15: 469-476. doi: 10.3923/pjbs.2012.469.476.
32. Instituto Brasileiro de Geografia e Estatística -IBGE. Pesquisa de orçamentos familiares 2008-2009: Aná lise do consumo alimentar pessoal no Brasil. http://www.ibge.gov.br/ home/estatistica/populacao/condicaodevida/pof/2008_2009_ analise_consumo/pofanalise_2008_2009.pdf.
33. Azevedo DV, Sampaio HAC. [Food consumption of pregnant adolescents assisted by prenatal service]. Rev Nutr Campinas 2003; 16: 273-280.
34. Fazio ES, Nomura RM, Dias MC, Zugaib M. [Dietary intake of pregnant women and maternal weight gain after nutritional counseling]. Rev Bras Ginecol Obstet 2011; 33: 87-92. doi: 10.1590/S0100-72032011000200006.
35. Nascimento E, Souza SB. [Evalutation of diet of overweight pregnant women]. Rev Nutr Campinas 2002; 15: 173-179.
36. Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM, Morris CD, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997; 337: 69-76. doi: 10.1056/NEJM1997 07103370201.
37. Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali MM, Zavaleta N, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006; 194: 639-649. doi: 10.1016/j.ajog.2006.01.068.